13F Pro

SEC Form 4 reporting owner

Guggenhime Andrew

Guggenhime Andrew has filed 17 Form 4 transactions reported between January 14, 2026 and September 8, 2026, as PRESIDENT AND CFO of Vaxcyte, Inc. and Director of Caribou Biosciences, Inc..

Name as filed: GUGGENHIME ANDREW

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$1.1M
4 lines
Companies
2
with Form 4 filings
Latest transaction
Sep 8, 2026
transaction date

Roles and reported holdings

  • PCVXVaxcyte, Inc.
    Jan 14, 2026 – Sep 8, 2026

    PRESIDENT AND CFO

    Held directly95,316 sh as of Sep 8, 2026 · Form 4

    24 months: $1.1M sold

  • CRBUCaribou Biosciences, Inc.
    Feb 20, 2026

    Director

    No common-stock holding reported on a purchase, sale, gift or withholding line.

Transaction history

All 17 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 8, 2026PCVXPRESIDENT AND CFOShares withheld for tax or exercise priceCode F · direct7,155$432K@ $60.36Form 4
Sep 2, 2026PCVXPRESIDENT AND CFOShares withheld for tax or exercise priceCode F · direct1,432$88K@ $61.58Form 4
Aug 31, 2026PCVXPRESIDENT AND CFOShares withheld for tax or exercise priceCode F · direct1,273$77K@ $60.74Form 4
Aug 3, 2026PCVXPRESIDENT AND CFOOpen-market saleCode S · direct3,044$165K@ $54.18Form 4
Aug 3, 2026PCVXPRESIDENT AND CFOOpen-market saleCode S · direct6,956$374K@ $53.76Form 4
Aug 3, 2026PCVXPRESIDENT AND CFOOption exerciseCode M · direct10,000$54K@ $5.35Form 4
Jul 6, 2026PCVXPRESIDENT AND CFOOpen-market saleCode S · direct2,087$121K@ $57.76Form 4
Jul 6, 2026PCVXPRESIDENT AND CFOOpen-market saleCode S · direct7,913$452K@ $57.16Form 4
Jul 6, 2026PCVXPRESIDENT AND CFOOption exerciseCode M · direct10,000$54K@ $5.35Form 4
Jun 18, 2026PCVXPRESIDENT AND CFOOption exerciseCode M · direct10,000$54K@ $5.35Form 4
Mar 9, 2026PCVXPRESIDENT AND CFOShares withheld for tax or exercise priceCode F · direct1,021$61K@ $59.32Form 4
Mar 2, 2026PCVXPRESIDENT AND CFOShares withheld for tax or exercise priceCode F · direct1,009$63K@ $61.98Form 4
Feb 28, 2026PCVXPRESIDENT AND CFOShares withheld for tax or exercise priceCode F · direct898$56K@ $61.98Form 4
Feb 26, 2026PCVXPRESIDENT AND CFOGrant or awardCode A · direct74,993—Form 4
Feb 26, 2026PCVXPRESIDENT AND CFOGrant or awardCode A · direct44,864—Form 4
Feb 20, 2026CRBUDirectorGrant or awardCode A · direct45,000—Form 4
Jan 14, 2026PCVXPRESIDENT AND CFOGiftCode G · direct61,850—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.